Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Bromoanisoles and methoxylated bromodiphenyl ethers in macroalgae from Nordic coastal regions.

Bidleman TF, Andersson A, Brugel S, Ericson L, Haglund P, Kupryianchyk D, Lau DCP, Liljelind P, Lundin L, Tysklind A, Tysklind M.

Environ Sci Process Impacts. 2019 May 22;21(5):881-892. doi: 10.1039/c9em00042a.

PMID:
31032511
2.

Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2018 update.

Tobe SW, Stone JA, Anderson T, Bacon S, Cheng AYY, Daskalopoulou SS, Ezekowitz JA, Gregoire JC, Gubitz G, Jain R, Keshavjee K, Lindsay P, L'Abbe M, Lau DCW, Leiter LA, O'Meara E, Pearson GJ, Rabi DM, Sherifali D, Selby P, Tu JV, Wharton S, Walker KM, Hua-Stewart D, Liu PP.

CMAJ. 2018 Oct 9;190(40):E1192-E1206. doi: 10.1503/cmaj.180194. No abstract available.

3.

Industrial and natural compounds in filter-feeding black fly larvae and water in 3 tundra streams.

Kupryianchyk D, Giesler R, Bidleman TF, Liljelind P, Lau DCP, Sponseller RA, Andersson PL.

Environ Toxicol Chem. 2018 Dec;37(12):3011-3017. doi: 10.1002/etc.4267. Epub 2018 Oct 26.

PMID:
30183099
4.

Weight Management in Diabetes.

Diabetes Canada Clinical Practice Guidelines Expert Committee, Wharton S, Pedersen SD, Lau DCW, Sharma AM.

Can J Diabetes. 2018 Apr;42 Suppl 1:S124-S129. doi: 10.1016/j.jcjd.2017.10.015. No abstract available.

PMID:
29650084
5.

Canadian Journal of Diabetes Welcomes a New Editor-In-Chief.

Lau DCW.

Can J Diabetes. 2017 Oct;41(5):467-468. doi: 10.1016/j.jcjd.2017.08.245. No abstract available.

PMID:
28942786
6.

Diabetes Canada and the Canadian Journal of Diabetes Affirm Their Mission to End Diabetes.

Lau DC.

Can J Diabetes. 2017 Apr;41(2):121-122. doi: 10.1016/j.jcjd.2017.02.004. No abstract available.

PMID:
28395814
7.

The 2014 summer coral bleaching event in subtropical Hong Kong.

Xie JY, Lau DCC, Kei K, Yu VPF, Chow WK, Qiu JW.

Mar Pollut Bull. 2017 Nov 30;124(2):653-659. doi: 10.1016/j.marpolbul.2017.03.061. Epub 2017 Apr 7.

PMID:
28392092
8.

Neuropsychiatric safety with liraglutide 3.0 mg for weight management: Results from randomized controlled phase 2 and 3a trials.

O'Neil PM, Aroda VR, Astrup A, Kushner R, Lau DCW, Wadden TA, Brett J, Cancino AP, Wilding JPH; Satiety and Clinical Adiposity - Liraglutide Evidence in individuals with and without diabetes (SCALE) study groups.

Diabetes Obes Metab. 2017 Nov;19(11):1529-1536. doi: 10.1111/dom.12963. Epub 2017 Jul 21.

9.

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.

le Roux CW, Astrup A, Fujioka K, Greenway F, Lau DCW, Van Gaal L, Ortiz RV, Wilding JPH, Skjøth TV, Manning LS, Pi-Sunyer X; SCALE Obesity Prediabetes NN8022-1839 Study Group.

Lancet. 2017 Apr 8;389(10077):1399-1409. doi: 10.1016/S0140-6736(17)30069-7. Epub 2017 Feb 23. Erratum in: Lancet. 2017 Apr 8;389(10077):1398.

PMID:
28237263
10.

Are Diabetes Care Providers Too Glucocentric?

Lau DC.

Can J Diabetes. 2016 Dec;40(6):479-481. doi: 10.1016/j.jcjd.2016.10.004. Epub 2016 Oct 31. No abstract available.

PMID:
27810227
11.

2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult.

Anderson TJ, Grégoire J, Pearson GJ, Barry AR, Couture P, Dawes M, Francis GA, Genest J Jr, Grover S, Gupta M, Hegele RA, Lau DC, Leiter LA, Lonn E, Mancini GB, McPherson R, Ngui D, Poirier P, Sievenpiper JL, Stone JA, Thanassoulis G, Ward R.

Can J Cardiol. 2016 Nov;32(11):1263-1282. doi: 10.1016/j.cjca.2016.07.510. Epub 2016 Jul 25. Review.

PMID:
27712954
12.

Tackling Peer Review: How to Improve Reviews and Minimize Abuse.

Lau DC.

Can J Diabetes. 2016 Apr;40(2):105-6. doi: 10.1016/j.jcjd.2016.02.004. Epub 2016 Mar 4. No abstract available.

PMID:
26952003
13.

Diabetes in the Elderly: A Silent Global Tsunami.

Lau DC.

Can J Diabetes. 2016 Feb;40(1):2-3. doi: 10.1016/j.jcjd.2015.12.003. Epub 2016 Jan 6. No abstract available.

PMID:
26778681
14.

Impact of Current and Emerging Glucose-Lowering Drugs on Body Weight in Type 2 Diabetes.

Lau DC, Teoh H.

Can J Diabetes. 2015 Dec;39 Suppl 5:S148-54. doi: 10.1016/j.jcjd.2015.09.090. Review.

PMID:
26654858
15.

Current and Emerging Pharmacotherapies for Weight Management in Prediabetes and Diabetes.

Lau DC, Teoh H.

Can J Diabetes. 2015 Dec;39 Suppl 5:S134-41. doi: 10.1016/j.jcjd.2015.10.001. Review.

PMID:
26654857
16.

Current and Emerging Pharmacotherapies for Type 2 Diabetes.

Lau DC.

Can J Diabetes. 2015 Dec;39 Suppl 5:S127-8. No abstract available.

PMID:
26653252
17.

Our journal: past, present and future.

Lau DC.

Can J Diabetes. 2015 Oct;39(5):345-6. doi: 10.1016/j.jcjd.2015.08.006. No abstract available.

PMID:
26443283
18.

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.

Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, Lau DC, le Roux CW, Violante Ortiz R, Jensen CB, Wilding JP; SCALE Obesity and Prediabetes NN8022-1839 Study Group.

N Engl J Med. 2015 Jul 2;373(1):11-22. doi: 10.1056/NEJMoa1411892.

19.

Addressing Conflict of Interest and Bias in Research, Education and Clinical Practice.

Lau DC.

Can J Diabetes. 2015 Aug;39(4):247-9. doi: 10.1016/j.jcjd.2015.06.002. Epub 2015 Jun 24. No abstract available.

PMID:
26116472
20.

Diabetes technology and devices transform the lives of people with diabetes.

Lau DC.

Can J Diabetes. 2015 Jun;39(3):174-5. doi: 10.1016/j.jcjd.2015.04.003. Epub 2015 Apr 28. No abstract available.

PMID:
25936901
21.

Recommendations for obesity management and prevention have come a long way.

Lau DC.

Can J Diabetes. 2015 Apr;39(2):89-90. doi: 10.1016/j.jcjd.2015.01.289. Epub 2015 Feb 20. No abstract available.

PMID:
25702861
22.

Weighing the benefits and risks of diabetes drugs: a call for a unified global approach.

Lau DC.

Can J Diabetes. 2015 Feb;39(1):1-2. doi: 10.1016/j.jcjd.2014.12.002. Epub 2014 Dec 31. No abstract available.

PMID:
25558012
23.

Response to a recently published Letter to the Editor in The Lancet.

Lau DC.

Can J Diabetes. 2015 Feb;39(1):3. doi: 10.1016/j.jcjd.2014.12.009. Epub 2014 Dec 31. No abstract available.

PMID:
25558011
24.

Years of life lost and healthy life-years lost from diabetes and cardiovascular disease in overweight and obese people: a modelling study.

Grover SA, Kaouache M, Rempel P, Joseph L, Dawes M, Lau DC, Lowensteyn I.

Lancet Diabetes Endocrinol. 2015 Feb;3(2):114-22. doi: 10.1016/S2213-8587(14)70229-3. Epub 2014 Dec 5.

PMID:
25483220
25.

Promoting healthful behaviour changes in people affected by diabetes.

Lau DC.

Can J Diabetes. 2014 Dec;38(6):377-8. doi: 10.1016/j.jcjd.2014.10.008. Epub 2014 Oct 25. No abstract available.

PMID:
25457564
26.

Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE): 2014 update.

Tobe SW, Stone JA, Walker KM, Anderson T, Bhattacharyya O, Cheng AY, Gregoire J, Gubitz G, L'Abbé M, Lau DC, Leiter LA, Oh P, Padwal R, Poirier L, Selby P, Tremblay M, Ward RA, Hua D, Liu PP; C-CHANGE Initiative.

CMAJ. 2014 Nov 18;186(17):1299-305. doi: 10.1503/cmaj.140387. Epub 2014 Oct 20. No abstract available.

27.

Do sugar-sweetened beverages cause adverse health outcomes in adults? A systematic review protocol.

Hamel C, Stevens A, Singh K, Ansari MT, Myers E, Ziegler P, Hutton B, Sharma A, Bjerre LM, Fenton S, Lau DC, O'Hara K, Reid R, Salewski E, Shrier I, Willows N, Tremblay M, Moher D.

Syst Rev. 2014 Sep 23;3:108. doi: 10.1186/2046-4053-3-108.

28.

Therapeutic inertia and nihilism.

Lau DC.

Can J Diabetes. 2014 Oct;38(5):290-1. doi: 10.1016/j.jcjd.2014.08.003. Epub 2014 Sep 3. No abstract available.

PMID:
25192955
29.

Canada welcomes a novel class of oral glucose-lowering drugs for people with type 2 diabetes.

Lau DC.

Can J Diabetes. 2014 Aug;38(4):219-20. doi: 10.1016/j.jcjd.2014.06.001. No abstract available.

PMID:
25092641
30.

Autochthonous resources are the main driver of consumer production in dystrophic boreal lakes.

Lau DC, Sundh I, Vrede T, Pickova J, Goedkoop W.

Ecology. 2014 Jun;95(6):1506-19.

PMID:
25039216
31.

The Sedentary Time and Activity Reporting Questionnaire (STAR-Q): reliability and validity against doubly labeled water and 7-day activity diaries.

Csizmadi I, Neilson HK, Kopciuk KA, Khandwala F, Liu A, Friedenreich CM, Yasui Y, Rabasa-Lhoret R, Bryant HE, Lau DC, Robson PJ.

Am J Epidemiol. 2014 Aug 15;180(4):424-35. doi: 10.1093/aje/kwu150. Epub 2014 Jul 19.

32.

Diabetes management in primary care.

Lau DC.

Can J Diabetes. 2014 Jun;38(3):157-8. doi: 10.1016/j.jcjd.2014.04.002. No abstract available.

PMID:
24909085
33.

Weight management in diabetes.

Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, Wharton S, Sharma AM, Lau DC.

Can J Diabetes. 2013 Apr;37 Suppl 1:S82-6. doi: 10.1016/j.jcjd.2013.01.025. Epub 2013 Mar 26. No abstract available.

PMID:
24070970
34.

Our mandate to optimize diabetes care and management.

Lau DC.

Can J Diabetes. 2014 Apr;38(2):73. doi: 10.1016/j.jcjd.2014.02.006. No abstract available.

PMID:
24690499
35.

Are the ACC/AHA guidelines on the treatment of blood cholesterol a game changer? A perspective from the Canadian Cardiovascular Society Dyslipidemia Panel.

Anderson TJ, Grégoire J, Hegele RA, Couture P, Mancini GB, McPherson R, Francis GA, Poirier P, Lau DC, Grover S, Genest J Jr, Carpentier AC, Dufour R, Gupta M, Ward R, Leiter LA, Lonn E, Ng DS, Pearson GJ, Yates GM, Stone JA, Ur E.

Can J Cardiol. 2014 Apr;30(4):377-80. doi: 10.1016/j.cjca.2014.01.009. Epub 2014 Jan 17. No abstract available.

PMID:
24589194
36.

Cardiovascular complications of diabetes.

Lau DC, Shen GX.

Can J Diabetes. 2013 Oct;37(5):279-81. doi: 10.1016/j.jcjd.2013.08.261. No abstract available.

PMID:
24500552
37.

Letter to the editor.

Lau DC.

Can J Diabetes. 2014 Feb;38(1):3-4. doi: 10.1016/j.jcjd.2013.12.005. No abstract available.

PMID:
24485204
38.

Snapshots of diabetes care in Canada.

Lau DC.

Can J Diabetes. 2014 Feb;38(1):1-2. doi: 10.1016/j.jcjd.2013.12.001. No abstract available.

PMID:
24485202
39.

Community-level destruction of hard corals by the sea urchin Diadema setosum.

Qiu JW, Lau DC, Cheang CC, Chow WK.

Mar Pollut Bull. 2014 Aug 30;85(2):783-8. doi: 10.1016/j.marpolbul.2013.12.012. Epub 2013 Dec 18.

PMID:
24360335
40.

The year in review: time to celebrate.

Lau DC.

Can J Diabetes. 2013 Dec;37(6):361-2. doi: 10.1016/j.jcjd.2013.10.004. No abstract available.

PMID:
24321714
41.

An urgent call for action: promoting healthy behaviour changes in Canada!

Lau DCW.

Can J Diabetes. 2013 Aug;37(4):211-212. doi: 10.1016/j.jcjd.2013.07.004. Epub 2013 Aug 2. No abstract available.

PMID:
24070881
42.

The Canadian Diabetes Association 2013 clinical practice guidelines-raising the bar and setting higher standards!

Cheng AY, Lau DC.

Can J Diabetes. 2013 Jun;37(3):137-8. doi: 10.1016/j.jcjd.2013.04.005. Epub 2013 May 29. No abstract available.

PMID:
24070834
43.

Benefits of modest weight loss on the management of type 2 diabetes mellitus.

Lau DC, Teoh H.

Can J Diabetes. 2013 Apr;37(2):128-34. doi: 10.1016/j.jcjd.2013.03.023. Epub 2013 Apr 23. Review.

PMID:
24070804
44.

Obesity and type 2 diabetes mellitus.

Sharma AM, Lau DC.

Can J Diabetes. 2013 Apr;37(2):63-4. doi: 10.1016/j.jcjd.2013.03.360. Epub 2013 Apr 23. No abstract available.

PMID:
24070794
45.

Case-control study of inflammatory markers and the risk of endometrial cancer.

Friedenreich CM, Langley AR, Speidel TP, Lau DC, Courneya KS, Csizmadi I, Magliocco AM, Yasui Y, Cook LS.

Eur J Cancer Prev. 2013 Jul;22(4):374-9. doi: 10.1097/CEJ.0b013e32835b3813.

PMID:
23702681
46.

A comparison of the assessment and management of cardiometabolic risk in patients with and without type 2 diabetes mellitus in Canadian primary care.

Teoh H, Després JP, Dufour R, Fitchett DH, Goldin L, Goodman SG, Harris SB, Langer A, Lau DC, Lonn EM, Mancini GB, McFarlane PA, Poirier P, Rabasa-Lhoret R, Tan MK, Leiter LA.

Diabetes Obes Metab. 2013 Dec;15(12):1093-100. doi: 10.1111/dom.12134. Epub 2013 Jun 11.

PMID:
23683111
47.

Identification and management of patients at elevated cardiometabolic risk in canadian primary care: how well are we doing?

Teoh H, Després JP, Dufour R, Fitchett DH, Goldin L, Goodman SG, Harris SB, Langer A, Lau DC, Lonn EM, John Mancini GB, McFarlane PA, Poirier P, Rabasa-Lhoret R, Tan MK, Leiter LA.

Can J Cardiol. 2013 Aug;29(8):960-8. doi: 10.1016/j.cjca.2012.12.001. Epub 2013 Mar 7.

PMID:
23465284
48.

2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult.

Anderson TJ, Grégoire J, Hegele RA, Couture P, Mancini GB, McPherson R, Francis GA, Poirier P, Lau DC, Grover S, Genest J Jr, Carpentier AC, Dufour R, Gupta M, Ward R, Leiter LA, Lonn E, Ng DS, Pearson GJ, Yates GM, Stone JA, Ur E.

Can J Cardiol. 2013 Feb;29(2):151-67. doi: 10.1016/j.cjca.2012.11.032. Review.

PMID:
23351925
49.

The Alberta moving beyond breast cancer (AMBER) cohort study: a prospective study of physical activity and health-related fitness in breast cancer survivors.

Courneya KS, Vallance JK, Culos-Reed SN, McNeely ML, Bell GJ, Mackey JR, Yasui Y, Yuan Y, Matthews CE, Lau DC, Cook D, Friedenreich CM.

BMC Cancer. 2012 Nov 16;12:525. doi: 10.1186/1471-2407-12-525.

50.

Case-control study of markers of insulin resistance and endometrial cancer risk.

Friedenreich CM, Langley AR, Speidel TP, Lau DC, Courneya KS, Csizmadi I, Magliocco AM, Yasui Y, Cook LS.

Endocr Relat Cancer. 2012 Nov 9;19(6):785-92. doi: 10.1530/ERC-12-0211. Print 2012 Dec.

Supplemental Content

Support Center